The company’s 1st MEA subsidiary positions it at the heart of one of the world’s fastest-growing healthcare regions, enhancing access to trusted, high-quality treatments. Dubai, United Arab Emirates. 17 December 2025. Greek pharmaceuticals manufacturer, ELPEN, today announced the launch of its 1st MEA subsidiary in the United Arab Emirates. The move marks a major milestone in … Continue reading ELPEN establishes 1st MEA subsidiary to expand access to high quality medicines across the region